Shilong Meng, Xu Zhang, Yang Yu, Minghao Tong, Yifeng Yuan, Yanguang Cao, Wei Zhang, Xiaolin Shi, Kang Liu
New-QiangGuYin (N-QGY), the addition of sea buckthorn on the basis of QGY formula, is herbal formula widely used clinically in China for the treatment of osteoporosis (OP), but its mechanism warrants further exploration. The mechanisms of QGY and N-QGY in the treatment of OP are probed from the perspective of osteoclast-osteoblast balance. Thirty Sprague-Dawley rats are randomly divided into N-QGY group, QGY group, and Control group. Beyond control rats that orally took normal saline, other rats are orally administered with isometric N-QGY or QGY twice every day for 3 days. The drug-containing serum and control serum are prepared and their effects on osteoclast-derived exosome secretion are determined by bicinchoninic acid assay (BCA), nanoparticle tracking analysis, and Western blot. GW4869 and Interleukin-1β (IL-1β) are adopted as the exosome inhibitor and inducer, respectively. Exosome uptake, cell counting kit-8, alkaline phosphatase (ALP) staining, alizarin red staining, enzyme-linked immunosorbent assay, quantitative real-time polymerase chain reaction, and Western blot are performed to examine the effects of altered osteoclast exosome content on osteogenic differentiation of mesenchymal stem cells (MSCs). N-QGY, QGY, and GW4869 inhibit osteoclast-derived exosome secretion and exosome uptake by MSCs, whereas IL-1β exerted the opposite effects (p < 0.05). Different from IL-1β, N-QGY, QGY, and GW4869 partially elevated MSC viability, osteocalcin secretion, ALP, RUNX Family Transcription Factor 2 (RUNX2) and Osteopontin (OPN) expressions, and calcium deposition in the osteoclast-MSCs coculture system (p < 0.05). Mechanically, osteoclasts increased Notum protein level but decreased β-catenin level, which is enhanced by IL-1β but is reversed by GW4869, QGY, and N-QGY (p < 0.05). And the effect of N-QGY is more conspicuous than that of QGY (P<0.05). N-QGY-containing serum inhibits exosome levels in osteoclasts, thereby enhancing osteogenic differentiation of MSCs via inhibition of Notum protein and promotion of β-catenin protein.
新羌活汤(New-QiangGuYin,N-QGY)是在羌活汤基础上加入沙棘的中药方剂,是中国临床上广泛用于治疗骨质疏松症(OP)的中药方剂,但其作用机制有待进一步探讨。本研究从破骨细胞-成骨细胞平衡的角度探讨了 QGY 和 N-QGY 治疗 OP 的机制。30 只 Sprague-Dawley 大鼠被随机分为 N-QGY 组、QGY 组和对照组。除口服生理盐水的对照组大鼠外,其他大鼠均口服等量 N-QGY 或 QGY,每天两次,连续 3 天。制备含药血清和对照血清,并通过双喹啉酸测定法(BCA)、纳米颗粒追踪分析法和 Western 印迹法测定其对破骨细胞外泌体分泌的影响。GW4869和白细胞介素-1β(IL-1β)分别作为外泌体抑制剂和诱导剂。通过外泌体摄取、细胞计数试剂盒-8、碱性磷酸酶(ALP)染色、茜素红染色、酶联免疫吸附试验、实时定量聚合酶链反应和 Western 印迹等方法,研究破骨细胞外泌体含量的改变对间充质干细胞(MSCs)成骨分化的影响。N-QGY、QGY 和 GW4869 可抑制破骨细胞源性外泌体的分泌和间充质干细胞对外泌体的吸收,而 IL-1β 则产生相反的作用(p<0.05)。
{"title":"New-QiangGuYin-Containing Serum Inhibits Osteoclast-Derived Exosome Secretion and Down-Regulates Notum to Promote Osteoblast Differentiation.","authors":"Shilong Meng, Xu Zhang, Yang Yu, Minghao Tong, Yifeng Yuan, Yanguang Cao, Wei Zhang, Xiaolin Shi, Kang Liu","doi":"10.1002/adbi.202400166","DOIUrl":"https://doi.org/10.1002/adbi.202400166","url":null,"abstract":"<p><p>New-QiangGuYin (N-QGY), the addition of sea buckthorn on the basis of QGY formula, is herbal formula widely used clinically in China for the treatment of osteoporosis (OP), but its mechanism warrants further exploration. The mechanisms of QGY and N-QGY in the treatment of OP are probed from the perspective of osteoclast-osteoblast balance. Thirty Sprague-Dawley rats are randomly divided into N-QGY group, QGY group, and Control group. Beyond control rats that orally took normal saline, other rats are orally administered with isometric N-QGY or QGY twice every day for 3 days. The drug-containing serum and control serum are prepared and their effects on osteoclast-derived exosome secretion are determined by bicinchoninic acid assay (BCA), nanoparticle tracking analysis, and Western blot. GW4869 and Interleukin-1β (IL-1β) are adopted as the exosome inhibitor and inducer, respectively. Exosome uptake, cell counting kit-8, alkaline phosphatase (ALP) staining, alizarin red staining, enzyme-linked immunosorbent assay, quantitative real-time polymerase chain reaction, and Western blot are performed to examine the effects of altered osteoclast exosome content on osteogenic differentiation of mesenchymal stem cells (MSCs). N-QGY, QGY, and GW4869 inhibit osteoclast-derived exosome secretion and exosome uptake by MSCs, whereas IL-1β exerted the opposite effects (p < 0.05). Different from IL-1β, N-QGY, QGY, and GW4869 partially elevated MSC viability, osteocalcin secretion, ALP, RUNX Family Transcription Factor 2 (RUNX2) and Osteopontin (OPN) expressions, and calcium deposition in the osteoclast-MSCs coculture system (p < 0.05). Mechanically, osteoclasts increased Notum protein level but decreased β-catenin level, which is enhanced by IL-1β but is reversed by GW4869, QGY, and N-QGY (p < 0.05). And the effect of N-QGY is more conspicuous than that of QGY (P<0.05). N-QGY-containing serum inhibits exosome levels in osteoclasts, thereby enhancing osteogenic differentiation of MSCs via inhibition of Notum protein and promotion of β-catenin protein.</p>","PeriodicalId":7234,"journal":{"name":"Advanced biology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141465506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vascular cognitive impairment (VCI) is a heterogenous form of cognitive impairment that results from cerebrovascular disease. It is a result of both genetic and non-genetic factors. Although much research has been conducted on the genetic contributors to other forms of cognitive impairment (e.g. Alzheimer's disease), knowledge is lacking on the genetic factors associated with VCI. A better understanding of the genetics of VCI will be critical for prevention and treatment. To begin to fill this gap, the genetic contributors are reviewed with VCI from the literature. Phenome-wide scans of the identified genes are conducted and genetic variants identified in the review in large-scale resources displaying genetic variant-trait association information. Gene set are also carried out enrichment analysis using the genes identified from the review. Thirty one articles are identified meeting the search criteria and filters, from which 107 unique protein-coding genes are noted related to VCI. The phenome-wide scans and gene set enrichment analysis identify pathways associated with a diverse set of biological systems. This results indicate that genes with evidence of involvement in VCI are involved in a diverse set of biological functions. This information can facilitate downstream research to better dissect possible shared biological mechanisms for future therapies.
{"title":"Systematic Review and Phenome-Wide Scans of Genetic Associations with Vascular Cognitive Impairment","authors":"Rime Diany, Sarah A Gagliano Taliun","doi":"10.1002/adbi.202300692","DOIUrl":"10.1002/adbi.202300692","url":null,"abstract":"<p>Vascular cognitive impairment (VCI) is a heterogenous form of cognitive impairment that results from cerebrovascular disease. It is a result of both genetic and non-genetic factors. Although much research has been conducted on the genetic contributors to other forms of cognitive impairment (e.g. Alzheimer's disease), knowledge is lacking on the genetic factors associated with VCI. A better understanding of the genetics of VCI will be critical for prevention and treatment. To begin to fill this gap, the genetic contributors are reviewed with VCI from the literature. Phenome-wide scans of the identified genes are conducted and genetic variants identified in the review in large-scale resources displaying genetic variant-trait association information. Gene set are also carried out enrichment analysis using the genes identified from the review. Thirty one articles are identified meeting the search criteria and filters, from which 107 unique protein-coding genes are noted related to VCI. The phenome-wide scans and gene set enrichment analysis identify pathways associated with a diverse set of biological systems. This results indicate that genes with evidence of involvement in VCI are involved in a diverse set of biological functions. This information can facilitate downstream research to better dissect possible shared biological mechanisms for future therapies.</p>","PeriodicalId":7234,"journal":{"name":"Advanced biology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/adbi.202300692","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141465507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p><b>Städler</b>: I became fascinated with the hierarchical structure of mammalian cells when writing my postdoc fellowship application back in 2007. At that point, encapsulated catalysis existed, but sub-compartmentalization was a very new concept. We invented capsosomes (liposomes as subunits in polymer multilayer capsules), a very simple artificial cell, especially when looking back. When I started my independent research group in Denmark, the question was never IF we will be working in the area of artificial biology, more WHICH of the many aspects, we will be focusing on. For me, the most fascinating questions were and remain around considerations of how to integrate a bottom-up assembled life-like unit with living mammalian cells.</p><p><b>Valero</b>: I have always been fascinated by how biological systems work. For a chemist, a cell is a paradigm of complexity, where highly efficient reactions, molecular interactions, self-assembly, nanomechanics, directional transport, etc., harmoniously converge in a single entity. Inspired by Richard Feynman's quote: “What I cannot create, I do not understand,” my approach to biological systems involves developing artificial prototypes based on nucleic acid building blocks that mimic the structures and functions displayed in nature. These artificial molecules not only contribute to shedding light on how biological systems work, but they can also exhibit novel and enhanced functionalities that can be integrated to create unique synthetic biology systems or used for biomedical applications.</p><p><b>Zelikin</b>: I am teaching medicinal chemistry and through this, I gained an understanding and appreciation of the molecular composition of a cell; it inspired me, and challenged me to pursue this elegance and complexity of composition via the bottom-up approach, using in-house made molecules.</p><p><b>Sanchez</b>: There are a few reasons: I always loved the idea of reproducing the complexity of living systems by engineering something with our own hands, trying to mimic at least one of the hallmarks of life. For instance, in our lab, we focus on motion, from single to collective phenomena. And I still want to combine these artificial systems with living/biological components, such as cells or enzymes. That is what we call hybrid systems.</p><p><b>Sanchez</b>: Definitely nanomedicine. With the combination of artificial and biological components, we can design better delivery vehicles that interact more efficiently with biological systems and biomaterials such as cells and tumors.</p><p><b>Valero</b>: I believe integration and adaptation to living organisms are key for the advancement of the field. We need to develop artificial systems that do not merely work in parallel but rather integrate with cells, tissues, and organs, offering feedback communication and the capability of adapting to their environment and physicochemical signaling. An advanced feature of future synthetic biology systems will be to combine t
生物伦理学和宗教科学专家。如果人工生物学的概念最终被考虑应用于临床,病人的看法将非常重要,而自我维持甚至自我复制的系统将引起伦理方面的关注:Städler:我的目标是在同一特刊中收集来自人工生物学不同领域的投稿,以说明该领域的跨学科性质。对我来说,如果我们能够吸引来自世界各地的研究小组、多年来取得成功的实验室以及将塑造科学未来的年轻研究小组带头人投稿,这期特刊就成功了:我们正试图建立一个社区,相互承认并建立合作伙伴关系,当然也要把这一科学领域展示为一门成熟的学科,它对其他学科有很多贡献。安德森:我们的目标是通过聚集不同学科的研究人员,分享他们最近在人工生物学领域的研究成果,来激励人工生物学研究。人工生物学是一个雄心勃勃的未来研究领域,旨在设计出类似生命的系统,并开发出新颖的技术解决方案。桑切斯:我希望能有更多关于纳米电机如何在生物医学应用领域取得进展的文章。此外,我还希望能看到一些稿件从根本上报道具有新功能、生物兼容材料或新推进机制的新型人工系统的构建:我对这本特刊的主要期望是汇集该领域的最新投稿,包括有可能发展和超越到其他研究领域的作品,同时也能影响和启发其他科学家。理想情况下,该特刊将涵盖人工生物学最重要的趋势和未来方向,为该领域的下一步发展提供共同基础。ZelikinDepartment of Chemistry, Aarhus University, Aarhus, DenmarkAssociate Professor Ebbe Sloth AndersenInterdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus, DenmarkProfessor Samuel Sánchez OrdóñezInstitute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Barcelona, SpainInstitució Catalana de Recerca I Estudis Avançats (ICREA), Barcelona, Spain
{"title":"Emerging Life Sciences Series: Q&A with the Editor: Artificial Biology – Assemble, Imitate, Adapt","authors":"","doi":"10.1002/adbi.202400256","DOIUrl":"10.1002/adbi.202400256","url":null,"abstract":"<p><b>Städler</b>: I became fascinated with the hierarchical structure of mammalian cells when writing my postdoc fellowship application back in 2007. At that point, encapsulated catalysis existed, but sub-compartmentalization was a very new concept. We invented capsosomes (liposomes as subunits in polymer multilayer capsules), a very simple artificial cell, especially when looking back. When I started my independent research group in Denmark, the question was never IF we will be working in the area of artificial biology, more WHICH of the many aspects, we will be focusing on. For me, the most fascinating questions were and remain around considerations of how to integrate a bottom-up assembled life-like unit with living mammalian cells.</p><p><b>Valero</b>: I have always been fascinated by how biological systems work. For a chemist, a cell is a paradigm of complexity, where highly efficient reactions, molecular interactions, self-assembly, nanomechanics, directional transport, etc., harmoniously converge in a single entity. Inspired by Richard Feynman's quote: “What I cannot create, I do not understand,” my approach to biological systems involves developing artificial prototypes based on nucleic acid building blocks that mimic the structures and functions displayed in nature. These artificial molecules not only contribute to shedding light on how biological systems work, but they can also exhibit novel and enhanced functionalities that can be integrated to create unique synthetic biology systems or used for biomedical applications.</p><p><b>Zelikin</b>: I am teaching medicinal chemistry and through this, I gained an understanding and appreciation of the molecular composition of a cell; it inspired me, and challenged me to pursue this elegance and complexity of composition via the bottom-up approach, using in-house made molecules.</p><p><b>Sanchez</b>: There are a few reasons: I always loved the idea of reproducing the complexity of living systems by engineering something with our own hands, trying to mimic at least one of the hallmarks of life. For instance, in our lab, we focus on motion, from single to collective phenomena. And I still want to combine these artificial systems with living/biological components, such as cells or enzymes. That is what we call hybrid systems.</p><p><b>Sanchez</b>: Definitely nanomedicine. With the combination of artificial and biological components, we can design better delivery vehicles that interact more efficiently with biological systems and biomaterials such as cells and tumors.</p><p><b>Valero</b>: I believe integration and adaptation to living organisms are key for the advancement of the field. We need to develop artificial systems that do not merely work in parallel but rather integrate with cells, tissues, and organs, offering feedback communication and the capability of adapting to their environment and physicochemical signaling. An advanced feature of future synthetic biology systems will be to combine t","PeriodicalId":7234,"journal":{"name":"Advanced biology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/adbi.202400256","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141454603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Wanqing Wang, Haoqing Yang, Zhipeng Fan, Ruitang Shi
Angiogenesis is the determining factor during dental pulp regeneration. Six-twelve leukemia (STL) is identified as a key regulatory factor on the biological function of dental pulp stem cells (DPSCs) under hypoxic conditions, but its effect on angiogenesis is unclear. Co-culture of DPSCs and human umbilical vein endothelial cells (HUVECs) is used to detect tubule formation ability in vitro and the angiogenesis ability in vivo. RNA-seq and bioinformatic analyses are performed to screen differentially expressed genes. Seahorse Cell Mito Stress Test is proceeded to exam mitochondrial respiration. STL decreased tubule formation and mitochondrial respiration of DPSCs in vitro and restrained the number of blood vessels and the expression of VEGF in new formed tissue in vivo. Furthermore, pretreating STL-depleted DPSCs with rotenone, a mitochondrial respiration inhibitor, counteracted the promoting effect of STL knockdown on tubule formation. Then, RNA-seq and bioinformatic analyses identified some angiogenesis relevant genes and pathways in STL-depleted DPSCs. And STL enhanced expression of mRNA-ring finger protein 217 (RNF217), which inhibited the tubule formation and mitochondrial respiration of DPSCs. STL inhibited the angiogenesis of DPSCs through depressing mitochondrial respiration by enhancing RNF217, indicating that STL is a potential target for angiogenesis of DPSCs.
{"title":"STL Inhibited Angiogenesis of DPSCs Through Depressing Mitochondrial Respiration by Enhancing RNF217","authors":"Wanqing Wang, Haoqing Yang, Zhipeng Fan, Ruitang Shi","doi":"10.1002/adbi.202400042","DOIUrl":"10.1002/adbi.202400042","url":null,"abstract":"<p>Angiogenesis is the determining factor during dental pulp regeneration. Six-twelve leukemia (STL) is identified as a key regulatory factor on the biological function of dental pulp stem cells (DPSCs) under hypoxic conditions, but its effect on angiogenesis is unclear. Co-culture of DPSCs and human umbilical vein endothelial cells (HUVECs) is used to detect tubule formation ability in vitro and the angiogenesis ability in vivo. RNA-seq and bioinformatic analyses are performed to screen differentially expressed genes. Seahorse Cell Mito Stress Test is proceeded to exam mitochondrial respiration. STL decreased tubule formation and mitochondrial respiration of DPSCs in vitro and restrained the number of blood vessels and the expression of VEGF in new formed tissue in vivo. Furthermore, pretreating STL-depleted DPSCs with rotenone, a mitochondrial respiration inhibitor, counteracted the promoting effect of STL knockdown on tubule formation. Then, RNA-seq and bioinformatic analyses identified some angiogenesis relevant genes and pathways in STL-depleted DPSCs. And STL enhanced expression of mRNA-ring finger protein 217 (RNF217), which inhibited the tubule formation and mitochondrial respiration of DPSCs. STL inhibited the angiogenesis of DPSCs through depressing mitochondrial respiration by enhancing RNF217, indicating that STL is a potential target for angiogenesis of DPSCs.</p>","PeriodicalId":7234,"journal":{"name":"Advanced biology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/adbi.202400042","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141330090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Site-directed mutagenesis for creating point mutations, sometimes, gives rise to plasmids carrying variable number tandem repeats (VNTRs) locally, which are arbitrarily regarded as polymerase chain reaction (PCR) related artifacts. Here, the alternative end-joining mechanism is reported rather than PCR artifacts accounts largely for that VNTRs formation and expansion. During generating a point mutation on GPLD1 gene, an unexpected formation of VNTRs employing the 31 bp mutagenesis primers is observed as the repeat unit in the pcDNA3.1-GPLD1 plasmid. The 31 bp VNTRs are formed in 24.75% of the resulting clones with copy number varied from 2 to 13. All repeat units are aligned with the same orientation as GPLD1 gene. 43.54% of the repeat junctions harbor nucleotide mutations while the rest don't. Their demonstrated short primers spanning the 3′ part of the mutagenesis primers are essential for initial creation of the 2-copy tandem repeats (TRs) in circular plasmids. The dimerization of mutagenesis primers by the alternative end-joining in a correct orientation is required for further expansion of the 2-copy TRs. Lastly, a half-double priming strategy is established, verified the findings and offered a simple method for VNTRs creation on coding genes in circular plasmids without junction mutations.
{"title":"Mechanistic Characterization of De Novo Generation of Variable Number Tandem Repeats in Circular Plasmids during Site-Directed Mutagenesis and Optimization for Coding Gene Application","authors":"Ziqi Hu, Guochao Lin, Mingzhu Zhang, Shengwen Piao, Jiankun Fan, Jichao Liu, Peng Liu, Songbin Fu, Wenjing Sun, Li Li, Xiaohong Qiu, Jinwei Zhang, Yu Yang, Chunshui Zhou","doi":"10.1002/adbi.202400084","DOIUrl":"10.1002/adbi.202400084","url":null,"abstract":"<p>Site-directed mutagenesis for creating point mutations, sometimes, gives rise to plasmids carrying variable number tandem repeats (VNTRs) locally, which are arbitrarily regarded as polymerase chain reaction (PCR) related artifacts. Here, the alternative end-joining mechanism is reported rather than PCR artifacts accounts largely for that VNTRs formation and expansion. During generating a point mutation on GPLD1 gene, an unexpected formation of VNTRs employing the 31 bp mutagenesis primers is observed as the repeat unit in the pcDNA3.1-GPLD1 plasmid. The 31 bp VNTRs are formed in 24.75% of the resulting clones with copy number varied from 2 to 13. All repeat units are aligned with the same orientation as GPLD1 gene. 43.54% of the repeat junctions harbor nucleotide mutations while the rest don't. Their demonstrated short primers spanning the 3′ part of the mutagenesis primers are essential for initial creation of the 2-copy tandem repeats (TRs) in circular plasmids. The dimerization of mutagenesis primers by the alternative end-joining in a correct orientation is required for further expansion of the 2-copy TRs. Lastly, a half-double priming strategy is established, verified the findings and offered a simple method for VNTRs creation on coding genes in circular plasmids without junction mutations.</p>","PeriodicalId":7234,"journal":{"name":"Advanced biology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141330089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Because aging and internally determined lifespan vary greatly between similar species it is now widely accepted that aging is an evolved trait, resulting in two classes of evolutionary aging theories: aging is programmed by complex biological mechanisms, and aging is not programmed. As recently as 2002 programmed aging is thought to be theoretically impossible. However, genetics discoveries, results of selective breeding, and other direct evidence strongly support the idea that aging creates an evolutionary advantage and that therefore complex biological mechanisms evolved that control aging in mammals and other multiparous organisms. Like life-cycle programs that control reproduction, growth, and menopause the aging program can adjust the aging trait during an individual's life to compensate for temporary or local changes in external conditions that alter the optimum lifespan for a particular species population. Genetics discoveries also strongly support the evolvability concept to the effect that sexually reproducing species can evolve design features that increase their ability to evolve, and that aging is one such feature. Genetics discoveries also prove that biological inheritance involves transmission of organism design information in digital form between parent and descendant of any organism. This has major implications for the evolution process.
{"title":"Mammal Aging as a Programmed Life Cycle Function – Resolving the Cause and Effect Conundrum","authors":"Theodore C. Goldsmith","doi":"10.1002/adbi.202300658","DOIUrl":"10.1002/adbi.202300658","url":null,"abstract":"<p>Because aging and internally determined lifespan vary greatly between similar species it is now widely accepted that aging is an evolved trait, resulting in two classes of evolutionary aging theories: aging is programmed by complex biological mechanisms, and aging is not programmed. As recently as 2002 programmed aging is thought to be theoretically impossible. However, genetics discoveries, results of selective breeding, and other direct evidence strongly support the idea that aging creates an evolutionary advantage and that therefore complex biological mechanisms evolved that control aging in mammals and other multiparous organisms. Like life-cycle programs that control reproduction, growth, and menopause the aging program can adjust the aging trait during an individual's life to compensate for temporary or local changes in external conditions that alter the optimum lifespan for a particular species population. Genetics discoveries also strongly support the <i>evolvability</i> concept to the effect that sexually reproducing species can evolve design features that increase their ability to evolve, and that aging is one such feature. Genetics discoveries also prove that biological inheritance involves transmission of organism design information in <i>digital form</i> between parent and descendant of any organism. This has major implications for the evolution process.</p>","PeriodicalId":7234,"journal":{"name":"Advanced biology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141330088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Patricia Schmidt, Alexander Perniss, Martin Bodenbenner-Tuerich, Silke Wiegand, Loic Briand, Klaus Deckmann
Urinary Tract Infection
Increased sugar concentrations display risk factors for infections. Article number 2400117 by Klaus Deckmann and co-workers clarifies sugar monitoring in the urethra. Urethral tuft cells (UTC) are sentinels monitoring the urethral lumen and initiating protective mechanisms. Monitoring occurs via two pathways. A UTC/Tas1R3 dependent and a Tas1R3 independent pathway, found in both UTC and in other urethral epithelial cells. Sugars increases detrusor muscle activity UTC/Tas1R3 dependently.